| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $103.3M | +8.2% |
| Cost of Revenue | $73.0M | -1.1% |
| Gross Profit | $30.3M | +56.2% |
| R&D Expense | $414K | +206.3% |
| SG&A Expense | $21.0M | +27.7% |
| Operating Income | $8.9M | +215.1% |
| Pre-tax Income | $8.3M | +284.9% |
| Income Tax | $2.0M | — |
| Net Income | $6.6M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.0M | +151.7% |
| Accounts Receivable | $7.9M | +15.0% |
| Inventory | $3.3M | -9.0% |
| Current Assets | $23.6M | +50.3% |
| Total Assets | $45.1M | +30.4% |
| Current Liabilities | $16.7M | +40.5% |
| Total Liabilities | $25.5M | +15.6% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.6M | +110.9% |
| Capital Expenditures | $786K | +32.5% |
| Investing Cash Flow | -$1.4M | -31.0% |
| Financing Cash Flow | -$3.5M | -299.2% |
| Free Cash Flow | $10.8M | +120.4% |
| +184.9% |
| EPS (Basic) | $0.18 | +200.0% |
| EPS (Diluted) | $0.17 | +183.3% |
| Stockholders' Equity |
| $19.6M |
| +56.5% |